Cytokinetics, Inc. (CYTK)

NASDAQ: CYTK · IEX Real-Time Price · USD
40.15
+0.86 (2.19%)
Jul 1, 2022 1:36 PM EDT - Market open

Stock Price Forecast

According to 19 stock analysts, the average 12-month stock price forecast for CYTK stock is $62.81, which predicts an increase of 56.44%. The lowest target is $46.46 and the highest is $84. On average, analysts rate CYTK stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $46.46 $62.81 $59.16 $84
Change +15.72% +56.44% +47.35% +109.22%

Analyst Ratings

The average analyst rating for CYTK stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 344444
Buy 131414141414
Hold 111111
Sell 000000
Strong Sell 000000
Total 171919191919

Financial Forecast

Revenue This Year
18.17M
Decreased by -74.20%
Revenue Next Year
80.61M
Increased by 343.70%
EPS This Year
-4.47
EPS Next Year
-4.37
Year 2017201820192020202120222023202420252026
Revenue
13.37M31.50M26.87M55.83M70.43M18.17M80.61M177.94M436.13M1.09B
Revenue Growth
-87.44%
135.64%
-14.71%
107.79%
26.15%
-74.20%
343.70%
120.73%
145.10%
150.00%
EPS
-2.59-1.95-2.11-1.97-2.80-4.47-4.37-3.60-3.88-4.27
EPS Growth
----------
No. Analysts -----15141288

Revenue Forecast

Revenue 20222023202420252026
High 26.3M 303.5M 535.5M 457.9M 1.1B
Avg 18.2M 80.6M 177.9M 436.1M 1.1B
Low 1.1M n/a n/a 423.0M 1.1B

Revenue Growth

Revenue Growth 20222023202420252026
High
21.0%
1,570.2%
564.3%
157.4%
160.0%
Avg
-16.3%
343.7%
120.7%
145.1%
150.0%
Low
-94.8%
- -
137.7%
142.5%

EPS Forecast

EPS 20222023202420252026
High -4.21 -2.05 -0.93 -4.08 -4.44
Avg -4.47 -4.37 -3.60 -3.88 -4.27
Low -4.73 -4.95 -4.62 -3.77 -4.14

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -